Myeloid-derived suppressor cells are increased in lung transplant recipients and regulated by immunosuppressive therapy

M Iglesias-Escudero, DS Segundo… - Frontiers in …, 2022 - frontiersin.org
Lung transplantation remains as a primary treatment for end-stage lung diseases. Although
remarkable improvement has been achieved due to the immunosuppressive protocols, long …

Variations in circulating active MMP-9 levels during renal replacement therapy

E Rodríguez-Sánchez, JA Navarro-García… - Biomolecules, 2020 - mdpi.com
Renal replacement therapy (RRT) is complicated by a chronic state of inflammation and a
high mortality risk. However, different RRT modalities can have a selective impact on …

Exploring the Relationship Between Circulating M-MDSC Numbers and Risk of Posttransplant Malignancy

P Riquelme - Transplantation, 2020 - journals.lww.com
In the current issue of Transplantation, Utrero-Rico et al1 report an association between risk
of posttransplant malignancy and peak monocytic myeloid-derived suppressor cell (M …

Human Myeloid-Derived suppressor cells in solid organ transplantation.

M Iglesias, D San Segundo… - Trends in …, 2021 - search.ebscohost.com
The balance between effector and regulatory immune cells needs a very exquisite balance
in the context of solid organ transplantation to avoid the rejection of the organ while …

Células linfoides innatas en el contexto de la alorrespuesta inmune en trasplante de órgano sólido

E Gómez Massa - 2020 - docta.ucm.es
Células linfoides innatas en el contexto de la alorrespuesta inmune en trasplante de
órgano sólido Page 1 UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD DE …